Rv3919c - p.Asp67His
Drug resistance types
0 Sensitive
0 RR-TB
2 HR-TB
6 MDR-TB
1 Pre-XDR-TB
0 XDR-TB
25 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage3 | 2 |
| lineage4.2.2 | 6 |
| lineage4.5 | 2 |
| lineage1.2.2.1 | 2 |
| lineage4.8 | 12 |
| lineage4.1 | 6 |
| lineage4.3.4.1 | 2 |
| lineage4.2.2.1 | 2 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 34 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR29096965 | Other | lineage3 | None | DRR130212 | Pre-XDR-TB | lineage4.2.2 | None | DRR189115 | Other | lineage4.2.2 | None | ERR11068285 | Other | lineage4.5 | None | ERR2515643 | MDR-TB | lineage1.2.2.1 | za | SRR11033591 | Other | lineage4.8 | None | SRR28239652 | Other | lineage4.1 | None | ERR13286158 | MDR-TB | lineage1.2.2.1 | None | SRR10397216 | Other | lineage4.8 | None | ERR8773970 | Other | lineage4.8 | None | SRR16087996 | Other | lineage4.8 | None | SRR28239830 | Other | lineage4.1 | None | ERR11068732 | Other | lineage4.5 | None | ERR13253896 | MDR-TB | lineage4.2.2 | None | SRR10397171 | Other | lineage4.8 | None | SRR18715219 | Other | lineage4.1 | None | SRR16115880 | HR-TB | lineage4.3.4.1 | None | SRR28240246 | Other | lineage4.1 | None | SRR28044447 | Other | lineage3 | None | ERR2510842 | MDR-TB | lineage4.2.2.1 | it | SRR16088434 | Other | lineage4.8 | None | SRR10397205 | Other | lineage4.8 | None | SRR18912984 | HR-TB | lineage4.3.4.1 | None | DRR130144 | MDR-TB | lineage4.2.2 | None | SRR5153596 | Other | lineage4.8 | None | DRR473683 | Other | lineage4.2.2 | None | SRR28239959 | Other | lineage4.8 | None | SRR3085249 | MDR-TB | lineage4.2.2.1 | None | SRR16088258 | Other | lineage4.8 | None | SRR28240110 | Other | lineage4.8 | None | DRR473779 | Other | lineage4.2.2 | None | SRR28239605 | Other | lineage4.1 | None | SRR16088273 | Other | lineage4.1 | None | ERR4800346 | Other | lineage4.8 | None |
|---|
